TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

Ann: VitroGro ECM CE Mark Approval Referred to MH, page-48

  1. COLINK60
    261 Posts.
    clock Created with Sketch.
    09/08/12
    08:22
    Post #: 10545461
    re: Ann: VitroGro ECM CE Mark Approval Referr... I always thought the human trials were the biggest hurdle, but discovering very fast, that naming the product category makes human trials low risk.
    TIS Price at posting: 41.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.